使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主
Operator
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the AMN Healthcare Fourth Quarter and Full Year 2019 Earnings Call.
各位女士、先生,感謝您耐心等候,歡迎參加 AMN Healthcare 2019 年第四季及全年財報電話會議。
(Operator Instructions) As a reminder, this conference is being recorded.
(接線員指示) 提醒各位,本次會議將被錄音。
I would now like to turn the conference over to your host, Randy Reece. Please go ahead.
現在我想把會議交給主持人 Randy Reece。請開始。
Randle G. Reece - Director of IR
Randle G. Reece - Director of IR
Good afternoon, everyone. Welcome to AMN Healthcare's Fourth Quarter and Full Year 2019 Earnings Call. A replay of this webcast will be available at amnhealthcare.investorroom.com, following the conclusion of this call. Details for the audio replay of the conference call also are in our earnings release issued this afternoon. Various remarks we make during this call about future expectations, projections, plans, events or circumstances constitute forward-looking statements. These statements reflect the company's current beliefs based upon information currently available to it. Our actual results may differ materially from those indicated by these forward-looking statements as a result of various factors, including those identified in our most recent Form 10-K and subsequent filings with the SEC.
各位下午好。歡迎參加 AMN Healthcare 2019 年第四季及全年財報電話會議。本次網路直播的重播將於本次電話會議結束後,在 amnhealthcare.investorroom.com 提供。本次電話會議的音訊重播細節亦載於我們今天下午發布的財報新聞稿中。我們在本次電話會議中就未來預期、預測、計畫、事件或情況所作的各項評論,均構成前瞻性陳述。這些陳述反映公司基於目前可取得資訊所持的現行信念。由於各種因素,我們的實際結果可能與這些前瞻性陳述所示者存在重大差異,其中包括我們最近一期 Form 10-K 及其後向美國證券交易委員會(SEC)提交之文件中所識別的因素。
The company does not intend to update the guidance or any forward-looking statements provided today prior to its next earnings release. This call contains certain non-GAAP financial information. Information regarding and reconciliations of these non-GAAP measures to the most directly comparable GAAP measures are included in our earnings release and on our financial reports page at amnhealthcare.investorroom.com.
公司無意在下一次財報發布前更新今日提供的指引或任何前瞻性陳述。本次電話會議包含若干非 GAAP 財務資訊。關於這些非 GAAP 指標以及其與最直接可比 GAAP 指標之調節資訊,已包含於我們的財報新聞稿中,並刊載於 amnhealthcare.investorroom.com 的財務報告頁面。
On the call today are Susan Salka, Chief Executive Officer; Brian Scott, Chief Financial Officer; Kelly Rakowski, President of Leadership and Search; Ralph Henderson, President of Professional Services and Staffing; and Dan White, President of Workforce Solutions.
今天參與電話會議的有:執行長 Susan Salka;財務長 Brian Scott;領導與搜尋事業群總裁 Kelly Rakowski;專業服務與派遣事業群總裁 Ralph Henderson;以及人力解決方案事業群總裁 Dan White。
I will now turn the call over to Susan.
現在我把電話會議交給 Susan。
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
Thanks so much, Randy, and welcome, everyone, to our fourth quarter and full year 2019 earnings call. The team at AMN is very excited to be entering this new decade in such a strong position and in a promising market. We continue to see the effects of an unprecedented demographic change, resulting in increased demand for health care services and significant workforce shortages. We help health care organizations successfully navigate this high-demand era with our total talent solutions. At the same time, the AMN commitment to social responsibility and good governance aligns with our clients' and other stakeholders' initiatives and enables us to make a greater positive impact in our communities. Our team has worked hard to become the most trusted, innovative expert in total talent solutions. Working together with health care organizations and professionals, we are always ready when our clients and their patients need us most.
非常感謝你,Randy,也歡迎各位參加我們 2019 年第四季及全年財報電話會議。AMN 團隊非常興奮能以如此強勁的態勢、在充滿前景的市場中邁入新的十年。我們持續看到前所未有的人口結構變化所帶來的影響,導致醫療服務需求增加以及顯著的人力短缺。我們透過全方位人才解決方案,協助醫療機構成功因應這個高需求時代。同時,AMN 對社會責任與良好治理的承諾,與客戶及其他利害關係人的倡議一致,並使我們能在社區中創造更大的正向影響。我們的團隊努力成為全方位人才解決方案中最值得信賴、最具創新力的專家。與醫療機構及專業人士攜手合作,我們隨時準備在客戶及其病患最需要我們的時候挺身而出。
Our strategy progressed in 2019 with the June acquisition of Advanced Medical, an innovative provider of therapy and nurse staffing to both health care facilities and schools. This acquisition provided us important capabilities and capacity to address the growing labor needs of our clients across multiple settings. Eight months into the integration, things are going very smoothly, and we continue to be impressed with the talent that has joined the AMN family.
我們的策略在 2019 年持續推進,並於 6 月完成對 Advanced Medical 的收購;該公司是為醫療機構與學校提供治療與護理派遣的創新供應商。這項收購為我們帶來重要的能力與產能,以因應客戶在多種場域日益成長的用工需求。整合進行至第八個月,一切進展非常順利,我們也持續對加入 AMN 大家庭的人才印象深刻。
Allied Staffing was a standout performer in 2019, reaching $323 million in annual revenue, 29% higher than the previous year. Other high-performing but smaller businesses included international nurse staffing, rapid response, labor disruption and our predictive analytics and scheduling business. Our Other Workforce Solutions segment revenue reached a record $477 million in 2019, reflecting AMN's focus on increasing our strategic workforce solutions capabilities. Within this segment, we consolidated our interim leadership and permanent placement businesses into an integrated leadership solutions division. This move strengthened our go-to-market strategy and bolstered support of our key brands. In January of 2020, we announced the signing of an agreement to acquire Stratus Video, the leader in providing remote video healthcare interpretation services. We are pleased to share that earlier this week, we received regulatory approval for this acquisition, and we expect to close tomorrow.
聯合醫療派遣(Allied Staffing)在 2019 年表現突出,全年營收達 3.23 億美元,較前一年成長 29%。其他表現亮眼但規模較小的業務包括:國際護理派遣、快速應變、勞動中斷,以及我們的預測分析與排班業務。我們的「其他人力解決方案」事業群 2019 年營收創下 4.77 億美元新高,反映 AMN 專注於提升策略性人力解決方案能力。在此事業群內,我們將臨時領導與永久安置業務整合為一個整合式領導解決方案部門。此舉強化了我們的市場推進策略,並提升對主要品牌的支援。2020 年 1 月,我們宣布簽署協議收購 Stratus Video,該公司是提供遠端視訊醫療口譯服務的領導者。我們很高興分享,本週稍早我們已取得此收購案的監管核准,並預期將於明日完成交割。
Qualified health care interpretation, which is mandated by federal and state regulations, is a service that many health care organizations do not have the resources to provide for themselves. This acquisition helps further AMN's ability to deliver quality, compassionate patient care and to increase efficiency. It also aligns with our commitment to equality and inclusion by supporting greater access to care for limited English-proficient patients, deaf and hard of hearing individuals along with their families.
合格的醫療口譯服務受聯邦與州法規要求,但許多醫療機構並無資源自行提供。此項收購將進一步提升 AMN 提供高品質、具同理心的病患照護並提高效率的能力。同時,透過支持英語能力有限的病患、聾人與重聽人士及其家屬獲得更大的就醫可近性,此收購亦與我們對平等與共融的承諾一致。
In our market leadership position, we feel a responsibility to develop more ways to help our clients deal with the intensifying challenges of labor supply and complex health care demands. Some of our new capabilities and solutions will come from internal development. For example, we are working with health care professionals to develop mobile applications designed to create a personalized experience. Our team is also providing ways for clinicians to seamlessly interact with us across multiple channels around the clock. For clients, we are enhancing their access to richer data and insights, and we are leveraging our investments in VMS, credentialing, scheduling and predictive analytics to create a more integrated platform. To further broaden our workforce technology solutions, we recently acquired b4health, a technology innovator with an integrated float pool management solution; and VMS for health care facilities. These are just a few examples of how AMN's strategy guides our decisions and execution.
身為市場領導者,我們認為自己有責任開發更多方式,協助客戶因應日益加劇的勞動供給挑戰與複雜的醫療需求。我們的一些新能力與解決方案將來自內部開發。例如,我們正與醫療專業人士合作開發行動應用程式,旨在打造個人化體驗。我們的團隊也在提供方法,讓臨床人員可全天候透過多種管道與我們無縫互動。對客戶而言,我們正在強化其取得更豐富資料與洞見的能力,並運用我們在 VMS、資格認證、排班與預測分析方面的投資,打造更整合的平台。為進一步擴大我們的人力科技解決方案,我們近期收購了 b4health——一家科技創新者,提供整合式浮動人力池(float pool)管理解決方案;以及面向醫療機構的 VMS。以上僅是 AMN 策略如何引導我們決策與執行的幾個例子。
Over the next year, we certainly have a lot of work to do to translate these investments into the expected benefits for our clients, candidates, patients, team members and our shareholders. Fortunately, we have an incredibly talented and committed team, and we feel extremely confident in our ability to meet our high expectations.
在接下來一年,我們確實有許多工作要做,將這些投資轉化為客戶、候選人、病患、團隊成員以及股東所期待的效益。所幸我們擁有一支極具才華且投入的團隊,並對達成我們的高標準期望充滿信心。
Now let's take a few moments to look in the rearview mirror and discuss our strong results for the fourth quarter. We reached another record high in revenue at $587 million. Gross margin was 33.6%, and adjusted EBITDA was $75 million or 12.9% of revenue. Our Nurse and Allied segment posted revenue of $389 million, 18% higher year-over-year with 6% organic growth. Segment revenue beat expectations on exceptional results in our labor disruption and rapid response nursing businesses. Our largest business, Travel Nurse Staffing, grew revenue 9% year-over-year. Demand remained very strong in the fourth quarter, and the strength has carried into 2020. Lately, hours and bill rates are also improving, but not quite enough to accelerate new supply into the industry.
現在讓我們花幾分鐘回顧一下,討論我們第四季的強勁成果。我們的營收再創新高,達 5.87 億美元。毛利率為 33.6%,調整後 EBITDA 為 7,500 萬美元,約占營收的 12.9%。我們的護理與聯合醫療(Nurse and Allied)事業群營收為 3.89 億美元,年增 18%,其中有機成長 6%。該事業群營收優於預期,主要受惠於我們在勞動中斷與快速應變護理業務的卓越表現。我們最大的業務——旅行護理派遣(Travel Nurse Staffing)營收年增 9%。第四季需求仍然非常強勁,且這股強勢已延續至 2020 年。近期工時與計費費率也在改善,但仍不足以加速新的供給進入產業。
Allied reported 45% revenue growth in the fourth quarter, including our acquisition of Advanced. Organic growth for the quarter was 7%. As we previously noted and expected, demand in Allied Staffing was tempered by a slowdown among our skilled nursing clients due to reimbursement changes. This has been offset by growth in other specialties, particularly speech therapy, imaging, respiratory and lab professionals.
聯合醫療(Allied)在第四季的營收成長 45%,其中包含對 Advanced 的收購貢獻。本季有機成長為 7%。如我們先前所提及並預期,受報銷制度變更影響,我們的專業護理機構客戶出現放緩,使聯合醫療派遣(Allied Staffing)的需求受到抑制。不過,其他專科的成長已抵銷此影響,尤其是語言治療、影像、呼吸治療以及實驗室專業人員。
In the first quarter, we expect Nurse and Allied revenue to be up 14% to 16% year-over-year, with a combination of organic growth and the benefit of our Advanced acquisition.
在第一季,我們預期護理與相關醫療(Nurse and Allied)營收將較去年同期成長14%至16%,成長動能來自有機成長與我們收購Advanced所帶來的效益。
In the Locum Tenens segment, fourth quarter revenue was $78 million. Volume was roughly in line with our expectations, but revenue was impacted by a higher mix of lower rate specialties and a negative sales adjustment. Recently, booking trends have been favorable, and we believe Locum's revenue will be flat to up slightly year-over-year in the first quarter.
在短期代班醫師(Locum Tenens)部門,第四季營收為7,800萬美元。量能大致符合我們的預期,但營收受到較高比例的低費率專科組合以及一項負向銷售調整的影響。近期預訂趨勢表現良好,我們認為第一季Locum營收將與去年同期持平或小幅成長。
Our Other Workforce Solutions segment recorded fourth quarter revenue of $120 million, up 2% year-over-year. Our leadership solutions division makes up more than half of this segment's revenue and had a very solid quarter of performance, growing revenue at 7% year-over-year. Our technology workforce solutions, which include our vendor management system and workforce optimization, performed well again and grew double digits year-over-year in the fourth quarter. The 1 business that was down year-over-year in this segment is revenue cycle solutions. This was due primarily to disruption created by some organizational changes we made throughout 2019. As we begin the new year, we expect gains in most of the businesses within this segment and are projecting the Other Workforce Solutions segment revenue to be up 2% to 3% year-over-year on an organic basis. With the addition of b4health and Stratus, the Other Workforce Solutions revenue is expected to be up 15% to 16% year-over-year in the first quarter.
我們的其他人力解決方案(Other Workforce Solutions)部門第四季營收為1.20億美元,較去年同期成長2%。我們的領導力解決方案事業部占該部門營收的一半以上,本季表現非常穩健,營收較去年同期成長7%。我們的科技人力解決方案(包含供應商管理系統與人力優化)再次表現良好,第四季營收較去年同期呈雙位數成長。該部門中唯一較去年同期下滑的業務是營收循環解決方案(revenue cycle solutions)。主要原因是我們在2019年進行的一些組織調整所造成的干擾。隨著新年度開始,我們預期該部門多數業務將有所改善,並預估其他人力解決方案部門在有機基礎下,營收將較去年同期成長2%至3%。隨著併入b4health與Stratus,其他人力解決方案第一季營收預期將較去年同期成長15%至16%。
Overall, we are very pleased with our latest results and the outlook for 2020. As importantly, we are proud of the impact and commitment to AMN's purpose shared by our extraordinary team members. Every day, I am inspired by the talent and passion exhibited by my colleagues through both our work with clients and health care professionals and in our communities. I can never say enough just how grateful we are for all they do.
整體而言,我們對最新的業績表現以及2020年的展望感到非常滿意。同樣重要的是,我們為傑出團隊成員共同展現對AMN使命的影響力與承諾而感到自豪。每天,我都受到同仁在服務客戶與醫療專業人員,以及在社區中所展現的才華與熱情所激勵。我再怎麼說都不足以表達我們對他們所做一切的感激。
In a few minutes, Kelly, Ralph and Dan will join us for the question-and-answer session. On future calls, we're going to mix things up a bit and we'll include 1 or 2 different leaders to discuss particular aspects of our business. For example, we expect to have 1 of the Stratus leaders join us on our next earnings call. We hope this will provide our investors and analysts with a broader and deeper view into the business.
幾分鐘後,Kelly、Ralph與Dan將加入我們的問答環節。在未來的電話會議中,我們會做一些調整,將邀請1到2位不同的領導者來討論我們業務的特定面向。例如,我們預期在下一次財報電話會議中,將邀請一位Stratus的領導者加入。我們希望這能讓投資人與分析師對公司業務有更廣、更深入的了解。
Now I will turn the call over to Brian, who will provide more insights into our financial results.
現在我將把電話會議交給Brian,他將就我們的財務結果提供更多洞見。
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Thank you, Susan, and good afternoon, everyone. Fourth quarter revenue of $587 million was above the high end of our guidance range. The outperformance came from our Nurse and Allied segment, with about $10 million more than expected revenue from labor disruption activity in the quarter. Reported revenue grew 3% sequentially and 11% year-over-year. On an organic basis, revenue was up 3%, both sequentially and year-over-year. Gross margin for the quarter was 33.6%, up 100 basis points from last year and 10 basis points from last quarter. The higher year-over-year margin resulted from an increase in the high-margin labor disruption revenue in the Nurse and Allied segments, along with a favorable business mix shift within our Other Workforce Solutions segment. Fourth quarter Nurse and Allied segment revenue was $389 million, 18% higher than prior year and up 7% sequentially. On an organic basis, segment revenue was up 6% over prior year driven by the increase in labor disruption revenue this quarter.
謝謝你,Susan,各位下午好。第四季營收為5.87億美元,高於我們指引區間的上緣。優於預期主要來自護理與相關醫療部門,本季因勞動中斷(labor disruption)相關活動帶來的營收約比預期多出1,000萬美元。公告營收較前一季成長3%,較去年同期成長11%。以有機基礎計算,營收較前一季與較去年同期皆成長3%。本季毛利率為33.6%,較去年同期提高100個基點,較上一季提高10個基點。毛利率較去年同期提升,主要來自護理與相關醫療部門高毛利的勞動中斷營收增加,以及其他人力解決方案部門內部業務組合轉佳。第四季護理與相關醫療部門營收為3.89億美元,較去年同期成長18%,較前一季成長7%。以有機基礎計算,該部門營收較去年同期成長6%,主要由本季勞動中斷營收增加所帶動。
Our rapid response and international businesses grew double digits over the prior year. The average Travel Nurse bill rate was up from the prior year by about 3%, reflecting an increase in rapid response assignments and some improvement in contracted bill rates.
我們的快速應變(rapid response)與國際業務較去年同期呈雙位數成長。旅行護理(Travel Nurse)平均帳單費率較去年同期約上升3%,反映快速應變派遣增加,以及合約帳單費率略有改善。
Nurse and Allied gross margin of 28.6% was 140 basis points better than prior year and up 70 basis points from prior quarter, due mainly to the higher-margin labor disruption and rapid response revenue. With this higher gross margin, segment EBITDA margin of 14.3% was 50 basis points higher than prior year and up 120 basis points sequentially.
護理與相關醫療毛利率為28.6%,較去年同期改善140個基點,較前一季提高70個基點,主要因高毛利的勞動中斷與快速應變營收增加。在較高毛利率帶動下,該部門EBITDA利潤率為14.3%,較去年同期提高50個基點,較前一季提高120個基點。
Fourth quarter Locum Tenens segment revenue of $78 million was 5% less than the prior year and down 7% on a sequential basis. As Susan noted, the quarter included unfavorable sales adjustments of about $1 million. Gross margin of 26.5% was 70 basis points lower than the prior year and 100 basis points down sequentially. This decline was a result of these higher-than-normal sales adjustments in the quarter, which had about 80 basis points impact on the margin.
第四季短期代班醫師(Locum Tenens)部門營收為7,800萬美元,較去年同期下降5%,較前一季下降7%。如Susan所提,本季包含約100萬美元的不利銷售調整。毛利率為26.5%,較去年同期低70個基點,較前一季下降100個基點。此下滑係因本季高於正常水準的銷售調整所致,對毛利率約造成80個基點的影響。
Segment EBITDA margin was 7.9%, with a lower gross margin offset by a $900,000 favorable malpractice reserve adjustment recorded in SG&A. Other Workforce Solutions segment revenue was $120 million in the fourth quarter, up 2% year-over-year and down 1% sequentially. Segment gross margin of 54.3% increased 260 basis points year-over-year, due mainly to a favorable business mix shift. Consolidated SG&A expenses were $133 million or 22.7% of revenue compared with $111 million or 21% of revenue in the same quarter last year. The year-over-year increase includes about $7 million of SG&A from the Advanced and Silversheet acquisitions, $5 million from an adjustment to the Advanced earn-out reserve, and $8 million higher employee-related expenses to drive our growth strategy.
部門EBITDA利潤率為7.9%,較低的毛利率被SG&A中認列的90萬美元有利醫療疏失準備金(malpractice reserve)調整所部分抵銷。其他人力解決方案部門第四季營收為1.20億美元,較去年同期成長2%,較前一季下降1%。部門毛利率為54.3%,較去年同期增加260個基點,主要因業務組合轉佳。合併SG&A費用為1.33億美元,占營收22.7%,相較去年同期為1.11億美元、占營收21%。年增主要包含:Advanced與Silversheet收購案帶來約700萬美元的SG&A、Advanced或有對價(earn-out)準備金調整5百萬美元,以及為推動成長策略而增加的員工相關費用8百萬美元。
Fourth quarter adjusted EBITDA of $75 million was 14% higher year-over-year. Adjusted EBITDA margin of 12.9% was 30 basis points higher than prior year-over-year and up 70 basis points sequentially. EBITDA margin in the quarter was above our guidance, in large part from the higher-than-expected labor disruption revenue.
第四季調整後EBITDA為7,500萬美元,較去年同期成長14%。調整後EBITDA利潤率為12.9%,較去年同期提高30個基點,較前一季提高70個基點。本季EBITDA利潤率高於我們的指引,主要原因是勞動中斷營收高於預期。
We reported net income of $27 million and diluted earnings per share of $0.58 in the fourth quarter. Adjusted earnings per share was $0.85 compared with $0.81 in the year ago quarter. Our GAAP income tax rate in the quarter was 28% and was 30% on an adjusted basis. Our tax rate is expected to be 30% in the first quarter. Cash provided by operations was $79 million for the quarter and $225 million for the full year. Days sales outstanding at quarter end was 55 days, a 9-day improvement from the same quarter last year. At December 31, our cash and equivalents totaled $83 million. Capital expenditures in the fourth quarter were $10 million.
第四季我們公告淨利為2,700萬美元,稀釋後每股盈餘為0.58美元。調整後每股盈餘為0.85美元,去年同期為0.81美元。本季GAAP所得稅率為28%,調整後基礎為30%。我們預期第一季稅率為30%。本季營運活動提供的現金為7,900萬美元,全年為2.25億美元。季末應收帳款週轉天數(DSO)為55天,較去年同期改善9天。截至12月31日,我們的現金及約當現金合計為8,300萬美元。第四季資本支出為1,000萬美元。
At quarter end, our total debt outstanding was $625 million, and our leverage ratio was 2x to 1. As Susan mentioned, we are expecting to close the Stratus Video acquisition tomorrow for a purchase price of $475 million. We intend to fund the purchase using a new 5-year $250 million term loan, a $175 million draw on our revolving credit facility and $50 million from cash on hand. The interest rate on both the term loan and revolver are calculated using a LIBOR rate plus a spread based on our leverage ratio, and will be approximately 3.5%, assuming a pro forma leverage ratio of 3.3x to 1 at closing.
截至季度末,我們的未償還總債務為6.25億美元,槓桿比率為2比1。如Susan所提到的,我們預計將於明天完成Stratus Video的收購,收購價格為4.75億美元。我們擬以一筆新的5年期2.5億美元定期貸款、從循環信用額度中提取1.75億美元,以及動用手頭現金5,000萬美元來為本次收購提供資金。定期貸款與循環貸款的利率皆以LIBOR利率加上依我們槓桿比率而定的利差計算;假設交割時備考槓桿比率為3.3比1,利率約為3.5%。
Now let's turn to first quarter guidance. The company expects consolidated revenue of $598 million to $605 million, up 12% to 14% year-over-year. This includes $15 million of revenue from Stratus Video from the date of acquisition. On an organic basis, consolidated revenue will be up 2% to 3%. Gross margin is projected to be 33.3% to 33.5%. SG&A expenses as a percent of revenue are expected to be 23.1% to 23.3%. Adjusted EBITDA margin is expected to be 12.3% to 12.5%. Included in SG&A is stock-based compensation expense of $5.3 million; and acquisition, integration and other extraordinary expenses of about $8 million. Other first quarter 2020 estimates include the following: interest expense of $9.8 million; depreciation expense of $7.5 million and amortization expense of $12.1 million. Diluted share count is expected to be 47.6 million shares. A couple of other items to note. We are just starting the intangible valuation analysis for Stratus, so the quarterly amortization expense is subject to change. In addition, the depreciation, amortization and interest expense amounts only reflect the impact of having Stratus in our results for half the quarter.
接下來談第一季指引。公司預期合併營收為5.98億至6.05億美元,年增12%至14%。其中包含自收購日起Stratus Video貢獻的1,500萬美元營收。以有機基礎計算,合併營收將年增2%至3%。毛利率預估為33.3%至33.5%。SG&A費用占營收比重預期為23.1%至23.3%。調整後EBITDA利潤率預期為12.3%至12.5%。SG&A中包含530萬美元的股票基礎薪酬費用;以及約800萬美元的收購、整合及其他非常項目費用。2020年第一季其他估計如下:利息費用980萬美元;折舊費用750萬美元;攤銷費用1,210萬美元。稀釋後股數預期為4,760萬股。另外還有幾點需要注意。我們才剛開始進行Stratus的無形資產估值分析,因此季度攤銷費用可能會變動。此外,折舊、攤銷與利息費用金額僅反映Stratus在本季中納入我們業績半個季度的影響。
And now we'd like to open up the call for questions.
現在我們想開放電話會議進入提問環節。
Operator
Operator
(Operator Instructions) First question comes from the line of Tobey Sommer from SunTrust.
(接線員指示)第一個問題來自SunTrust的Tobey Sommer。
Tobey O'Brien Sommer - MD
Tobey O'Brien Sommer - MD
I was wondering if you could comment on what you think is required to start to drive bill rates sufficiently higher such that draws new supply into the nurse staffing market?
我想請問,你們認為要讓帳單費率(bill rates)提高到足以吸引新的供給進入護理人力派遣市場,需要具備哪些條件?
Ralph S. Henderson - President of Professional Services & Staffing
Ralph S. Henderson - President of Professional Services & Staffing
Tobey, this is Ralph. Thank you for the question. We did see some improvement in the quarter. I think we called that out, up about 3%. And we are -- our Q1 guidance actually has it strengthening just a little bit. We're not back to 2017 levels. So I would guess that's probably another 2 or 3 points from where we're at, at the end of first quarter. So it would be very helpful in terms of getting that supply to come back into Travel Nursing as well as our Allied and our Locums businesses, too, where pricing has been pretty tepid over the past 3 years.
Tobey,我是Ralph。謝謝你的問題。我們在本季度確實看到一些改善。我想我們也提到過,大約提升了3%。而且我們——我們對第一季的指引其實也預期會再小幅走強一些。我們還沒有回到2017年的水準。所以我猜大概還差2到3個百分點,相較於第一季末我們目前所在的位置。因此,這將非常有助於讓供給回流到旅遊護理(Travel Nursing),以及我們的Allied與Locums業務,因為過去3年定價一直相當疲弱。
Tobey O'Brien Sommer - MD
Tobey O'Brien Sommer - MD
So if you have the bill rate strengthening a bit, then the guidance is, is almost all the revenue growth just from price?
所以如果帳單費率有所走強,那麼指引所反映的營收成長,幾乎都是來自價格嗎?
Ralph S. Henderson - President of Professional Services & Staffing
Ralph S. Henderson - President of Professional Services & Staffing
No. It's not. I think it's -- and Brian might know the exact mix. I think some of it's from price, some of it's from volume, but we also have some headwinds in the -- if you're talking about the Allied business, for example, our skilled nursing facilities business is off quite a bit in the first quarter and being offset by increases in other areas of the business.
不是。並不是。我認為——Brian可能更清楚確切的組合。我想一部分來自價格,一部分來自量,但我們也面臨一些逆風——如果你談的是Allied業務,例如,我們的專業護理機構(skilled nursing facilities)業務在第一季下滑不少,但被其他業務領域的成長所抵消。
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Tobey, this is Brian. On the traditional Travel Nurse business, we're still working through some of the headwinds we've talked about in 2019. But that gap is narrowing significantly. So there's a little more price in the first quarter, but we're still seeing growth in our international business. We talked about the rapid response, and now we're seeing that the traditional Travel Nurse improve month-by-month as well.
Tobey,我是Brian。在傳統的旅遊護理業務方面,我們仍在消化我們在2019年談到的一些逆風。但那個差距正在顯著縮小。所以第一季價格因素會多一些,但我們仍看到國際業務在成長。我們談過快速應變(rapid response),而現在我們也看到傳統旅遊護理同樣在逐月改善。
Tobey O'Brien Sommer - MD
Tobey O'Brien Sommer - MD
Okay. I wanted to ask a question on the Locum Tenens space. Could you just kind of talk about the competitive positioning of the business in the market, where you see the industry growth rate? And then I'm interested in the VMS in the Locum space. There have been some strategic moves in the industry. And I'm curious on your perspective there, too.
好的。我想問一個關於Locum Tenens領域的問題。你們能否談談該業務在市場中的競爭定位、你們認為產業成長率在哪裡?另外我也對Locum領域的VMS很感興趣。產業內有一些策略性動作。我也想聽聽你們對此的看法。
Ralph S. Henderson - President of Professional Services & Staffing
Ralph S. Henderson - President of Professional Services & Staffing
This is Ralph. I'll take the first shot. And if anyone else has anything else to add, that would be great. On the market growth rate, we -- it has slowed. We generally said it was probably in the 3% to 5% range over the past several years. But because of pretty significant decreases in emergency medicine and hospitalists, it's probably closer to flat to up slightly. And almost all growth probably there driven by bill rate.
我是Ralph。我先回答第一部分。如果其他人還有補充也很好。就市場成長率而言,我們——它已經放緩。過去幾年我們一般說大概在3%到5%的區間。但由於急診醫學與住院醫師(hospitalists)出現相當明顯的下滑,整體可能更接近持平到小幅成長。而且幾乎所有成長大概都是由帳單費率所驅動。
The VMS marketplace has begun to change. I think now all of the top providers have some sort of anchor in the VMS world, as -- previously, I think, when we launched Locums MSP 6 years ago now, we were probably 1 of 2 players in that marketplace. Now there are more in the market.
VMS市場已開始改變。我認為現在所有頂尖供應商在VMS領域都有某種據點;而在先前——我想當我們在6年前推出Locums MSP時——我們大概是該市場中僅有的兩家業者之一。現在市場上有更多參與者。
And there was a third part to that question, which I want to make sure -- so just our positioning in the market. We are -- we've gone through our kind of the difficult period of getting to kind of a 1-firm look as opposed to 3 separate businesses. We have technology in place that allows us to execute better than we were able to as 3 separate businesses. And so I think we're starting to see some return to growth. If you take out those 2 specialties, for example, in the fourth quarter, if you took out hospitalist, emergency medicine, our growth would have been 9% across the other specialties up year-over-year.
另外你問題還有第三部分,我想確保——也就是我們在市場中的定位。我們——我們已經走過那段艱難的時期,從3個獨立業務整合成更像「單一公司」的樣貌。我們已建置技術,使我們能比過去以3個獨立業務運作時執行得更好。因此我認為我們開始看到一些成長回歸。例如在第四季,如果把住院醫師與急診醫學這兩個專科排除,我們在其他專科的年增率會是9%。
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
And Tobey, just a little bit more insight on our strategy as it relates to positioning of Locums. We very deliberately have been working with our MSP partners, both those MSP partners that might only use Locums, but even more so, those that want more of a whole house total talent solution provider who can provide not just Locums, but Nursing and Allied and perm as well as contingent. And in some cases, they want us to bring in non-clinical partners. And so we've very deliberately been focused on those kinds of more system types clients that might use multiple solutions and services. It might be in MSP and might be a VMS, which we can also support through our Medefis platform. And so I think you're seeing more of the competitive landscape change so that others that are sort of mid-to-larger size, also are seeing that they need to have those kinds of capabilities because it's what the clients want. They need the analytics, they need to get their arms around what they're spending. In some cases, they want a single provider, a single partner, that can provide all of those solutions. So I'm not at all surprised to see some of the competitors that have been resistant to workforce solutions and VMS now start to change their positioning a bit.
Tobey,再補充一點我們與Locums定位相關的策略洞見。我們非常有意識地與MSP合作夥伴合作——包括那些可能只使用Locums的MSP夥伴,但更重要的是那些希望有更完整、全院(whole house)的整體人才解決方案供應商,能提供不只是Locums,還包括護理(Nursing)、Allied、正職(perm)以及約聘(contingent)。在某些情況下,他們也希望我們引入非臨床合作夥伴。因此我們非常刻意地聚焦在這類更偏系統型(system types)的客戶,他們可能會使用多種解決方案與服務。可能是在MSP,也可能是VMS;我們也能透過我們的Medefis平台提供支援。因此我認為你會看到競爭版圖正在改變:其他一些中型到較大型的同業也意識到他們需要具備這些能力,因為這是客戶想要的。他們需要分析能力,需要掌握他們的支出。在某些情況下,他們希望有單一供應商、單一合作夥伴,能提供所有這些解決方案。所以我一點也不意外看到一些過去對人力解決方案與VMS較為抗拒的競爭對手,現在開始稍微調整他們的定位。
Tobey O'Brien Sommer - MD
Tobey O'Brien Sommer - MD
Okay. Last question for me, Susan. Could you comment about where we are in your kind of position in being poised to update us on long-term financial goals and targets for the firm?
好的。我這邊最後一個問題,Susan。你能否評論一下,我們目前所處的位置是否已經準備好向我們更新公司長期財務目標與指標?
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
Sure. It's really an interesting time, Tobey, as we reflect back even over the last decade, just for a moment. When we were coming into 2010, I think, 2009, our revenue was around $750 million. And here we are today, more than 3x that size. We've also increased our market cap, of course, significantly, probably more like 10x over that period. And that's been done through this evolution of Workforce Solutions. And starting with MSP, but then adding in VMS and all of the other businesses that we've added into the organization in order to serve our clients better, but also, as you can imagine, to create a better financial profile. And you've been there every step of the way along with us. So I don't need to go through it all with you. But I bring that up because I see 2020 as another major step in AMN's evolution as we position ourselves to be that total talent solution partner for clients. Quite honestly, we've already surpassed our previously stated goal of hitting an enterprise value of $4 billion. We had hoped to get there by more like 2022. And here we are today. So I think that's a really good sign that we can lay out goals and achieve them. One of those goals, as you recall, was also around margins, and EBITDA margins in particular. We certainly have made some good progress in some of our businesses, but because of the lack of growth that we expected in some of our staffing businesses and with Locums taking a bit of a step back, that held us back in achieving it. I do think that the demand environment that we have today and the progress that we're seeing in bill rates could provide for that kind of an environment to achieve those types of margins. And certainly, acquisitions like Stratus Video, go a long way in giving us a bigger step towards that. We'll add about 80 basis points to our EBITDA margins on an annualized basis just with that acquisition. So we're still very focused on those goals. We aren't prepared to set out a date for that quite yet. But hopefully, it gives you an idea of kind of where I think we are and the opportunity that still lies ahead of us.
當然可以。Tobey,這確實是一個很有意思的時點,讓我們先花一點時間回顧過去十年。我記得在我們進入2010年時(大概是2009年),營收約為7.5億美元。而今天,我們的規模已經超過當時的3倍。當然,我們的市值也大幅提升,在那段期間可能更接近成長了10倍。這些成果是透過Workforce Solutions(人力解決方案)的演進所達成的。從MSP開始,接著加入VMS以及我們為了更好地服務客戶而納入組織的其他各項業務;同時,如你所想像,這也有助於打造更佳的財務輪廓。而你一路以來也與我們並肩走過每一步。所以我不需要把所有細節再跟你重述一遍。但我之所以提到這些,是因為我把2020年視為AMN演進的另一個重大步驟:我們正把自己定位為客戶的全方位人才解決方案夥伴。坦白說,我們已經超越先前所提出的目標——企業價值達到40億美元。我們原本希望大概在2022年前後達成。但現在我們已經做到了。因此我認為這是一個非常好的訊號,顯示我們能夠訂定目標並加以實現。你也記得,其中一項目標與利潤率有關,特別是EBITDA利潤率。我們在部分業務確實取得不錯的進展,但由於某些派遣(staffing)業務的成長不如預期,加上Locums(代班醫師)業務稍微回落,這使我們在達成該目標上受到一些拖累。我確實認為,當前的需求環境以及我們在計費費率(bill rates)上看到的進展,可能提供一個有利於達成這類利潤率的環境。而像Stratus Video這樣的併購,也在推動我們朝該方向邁出更大一步方面發揮很大作用。僅就這項收購而言,按年化計算,我們的EBITDA利潤率將提升約80個基點。所以我們仍然非常聚焦於這些目標。目前我們還沒準備好為此訂出一個明確的時間點。但希望這能讓你對我認為我們目前所處的位置,以及未來仍存在的機會,有一個大致的概念。
Operator
Operator
Question comes from the line of A.J. Rice from Crédit Suisse.
下一個問題來自瑞士信貸(Crédit Suisse)的A.J. Rice。
Caleb Benjamin Harris - Research Analyst
Caleb Benjamin Harris - Research Analyst
This is Caleb Harris on for A.J. Just wanted to touch on demand a little bit more. I think last quarter, you said that the fourth quarter is expected to be a little bit weaker than usual with winter assignments coming later in the season. Can you comment on that, on what you're seeing on your orders for the first quarter? And then anything around the flu, if that's causing any increase in orders?
我是代替A.J.的Caleb Harris。我想再多談一點需求面。我記得上季你們提到,第四季預期會比往常稍弱一些,因為冬季派遣任務會在季節中較晚才開始。你能否就此評論一下,談談你們在第一季訂單上看到的情況?另外,流感是否帶來任何訂單增加?
Ralph S. Henderson - President of Professional Services & Staffing
Ralph S. Henderson - President of Professional Services & Staffing
Caleb, this is Ralph. Thanks for the question. We have seen positive demand trends across all of our businesses. So I'll start higher level, our Nursing, our Allied and our Locums businesses have all seen an increase in demand overall. Our Q4 demand was above prior year. And I think on our last call, we talked about that being in the neighborhood of 20% above prior year. But you're right, our winter needs, particularly those from one of our larger customers, got pushed to start a little bit later in January. And so we have seen those needs, and we have done a good job of meeting those requirements for those winter needs customers. So Q1 demand remains about the same as Q4 in terms of year-over-year acceleration to demand.
Caleb,我是Ralph。謝謝你的提問。我們在所有業務線都看到正向的需求趨勢。先從較高層次來看,我們的護理(Nursing)、醫療輔助(Allied)以及Locums(代班醫師)業務,整體需求都出現成長。我們第四季的需求高於去年同期。我想在上次電話會議中我們提到,大約是比去年同期高出20%左右。但你說得沒錯,我們的冬季需求,特別是來自某個較大型客戶的需求,被延後到1月稍晚才開始。因此我們確實看到了這些需求,而且我們在滿足這些冬季需求客戶的要求方面做得很好。所以就需求的年增加速幅度而言,第一季需求大致與第四季相當。
On the flu season, we haven't seen very much activity, a very small amount of activity related to the flu. Although the incidences of flu occurring are higher, whether or not that sends somebody into one of the environments that we staff, it doesn't seem to be having an impact. Just a very, very small impact. And that doesn't mean that it won't come. Maybe tomorrow something changes, and we've been surprised before by that. But at this point, kind of no flu in our guidance and no incremental flu expected.
至於流感季,我們沒有看到太多活動,與流感相關的需求只占非常小的一部分。雖然流感發生率較高,但是否會讓病患進入我們所配置人力的那些場域,似乎並未造成影響。影響非常、非常小。當然,這不代表之後不會發生。也許明天情況就改變了,我們以前也曾因此感到意外。但就目前而言,我們的指引中基本上沒有納入流感因素,也不預期會有額外的流感增量需求。
Kelly E. Rakowski - President of Leadership & Search Solutions
Kelly E. Rakowski - President of Leadership & Search Solutions
And Caleb, this is Kelly Rakowski. I'll just chime in a little bit on what we're seeing on the leadership and perm side as well. On the physician perm, we saw a significant increase in demand sequentially over the last couple of quarters and significantly over last year, and we continue to see that, particularly as larger systems have demand for primary care, behavioral health and medical specialties. And we're seeing their behaviors change, as Susan mentioned, more to a total talent partner and a strategic partnership where we're working side-by-side with them. Our interim leadership, highest level of assigned interim leaders in the last quarter, although we did see a little bit of softness in demand. And we think that is tied to some of the nursing trends that Ralph just mentioned as well. But we're starting to see that come back now as we start the year.
Caleb,我是Kelly Rakowski。我也補充一下我們在領導力與永久聘用(perm)端所看到的情況。在醫師永久聘用方面,過去幾個季度我們看到需求環比大幅增加,且相較去年也顯著成長;我們仍持續看到這樣的趨勢,尤其是大型醫療體系對基層醫療、行為健康以及醫療專科的需求增加。而且我們也看到他們的行為正在改變,如Susan所提到的,更傾向把我們視為全方位人才夥伴,並建立策略性合作關係,讓我們與他們並肩合作。至於臨時管理層(interim leadership),上季我們的在任臨時主管指派數量達到近期最高水準,儘管我們確實看到需求略有走弱。我們認為這也與Ralph剛提到的一些護理趨勢有關。但隨著新年度開始,我們現在開始看到需求回升。
Caleb Benjamin Harris - Research Analyst
Caleb Benjamin Harris - Research Analyst
Okay. Great. And I wanted to touch on the b4health acquisition that you mentioned, was that -- how sizable was that sort of financial impact? And I know you mentioned they had some sort of VMS solution. Were they a key competitor in that area? And what was sort of the strategic and/or financial rationale there?
好的。很好。我也想談一下你提到的b4health收購案——那個財務影響大概有多大?另外我知道你提到他們有某種VMS解決方案。他們在那個領域是主要競爭對手嗎?那麼在策略面和/或財務面的考量是什麼?
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
Sure, Caleb. It's Susan. I'll take that. So the revenue that they'll be bringing into the quarter is a little over $1 million a quarter. They're growing very nicely. They have a very innovative team and technology that's focused in a few different areas. One is the float pool management solution that I mentioned. They've really done a fantastic job of building a tool that helps clients create efficiency in the way that they manage their internal float pools, which, as you can imagine, for any individual hospital, but even more for large systems, is a very complex and burdensome part of their staffing equation. But more than just a tool to manage that, they have integrated it into other workforce systems, including other VMSs, so that the system itself through setting up particular rules, can do a great job of ensuring that if jobs aren't filled by the internal staff floating, it's quickly relayed to staffing partners. So they've had some fantastic clients. We've been certainly asked for this type of solution from other AMN clients. And we have other things in the works, but this will accelerate our ability to really go to market with a solution that is -- has a widespread need. And we'll, again, create a lot of efficiency and optimization of the limited staff that's out there. In addition, they also have a fantastic VMS tool that can be used by facilities who want to manage their staffing vendors in-house, or it can be actually utilized, and is utilized, by other MSP providers. They have some fantastic MSP clients within the industry. So we think it's a great team, a great technology, and they're already working very well with the AMN team overall.
當然可以,Caleb。我是 Susan。我來回答這個。因此,他們在單一季度將帶進來的營收略高於每季 100 萬美元。他們成長得非常不錯。他們擁有非常具創新性的團隊與技術,聚焦在幾個不同領域。其中之一是我提到的浮動人力池(float pool)管理解決方案。他們在打造一套工具方面做得非常出色,能協助客戶提升管理內部浮動人力池的效率;如你所想像,對任何單一醫院而言,尤其對大型醫療體系而言,這都是其人力配置方程式中非常複雜且負擔沉重的一環。但他們不僅僅提供管理工具,還把它整合進其他人力系統中,包括其他 VMS,因此系統本身透過設定特定規則,能非常有效地確保:若職缺未能由內部浮動人員補上,便能迅速轉交給人力派遣合作夥伴。所以他們擁有一些非常出色的客戶。我們也確實收到其他 AMN 客戶對這類解決方案的需求。我們也在推進其他方案,但這將加速我們真正把一個—具有廣泛需求的解決方案—推向市場的能力。而且它將再次為市場上有限的人力帶來大量效率提升與最佳化。此外,他們也有一個非常出色的 VMS 工具,可供希望在院內自行管理其人力供應商的機構使用;或者它也可以被其他 MSP 供應商採用,而且確實已被採用。他們在業界也有一些非常優秀的 MSP 客戶。因此我們認為這是一個很棒的團隊、很棒的技術,而且他們已經與 AMN 團隊整體合作得非常順暢。
Caleb Benjamin Harris - Research Analyst
Caleb Benjamin Harris - Research Analyst
Okay. And then just one more, sort of similar to Tobey's question on the Locums side, more in the Nurse, the Travel Nurse specifically, and Travel and Allied, Nurse and Allied, more broadly. What do you view as the market growth rate at this point? Sort of the 2% to 4% that you guys were talking about in Travel? Or is it something different than that?
好的。那再問一個,算是和 Tobey 在 Locums(代班醫師)那邊的問題類似,但更聚焦在護理端,特別是旅遊護理(Travel Nurse),以及更廣義的旅遊與醫事專業(Travel and Allied),也就是護理與 Allied。你們目前怎麼看市場成長率?是你們在旅遊(Travel)提到的 2% 到 4% 嗎?還是會不一樣?
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
Well, I would look at it first more -- I'll start with nursing, and I'll ask, of course, Ralph, to chime in here if I leave something out. But I would think of Travel Nursing as all-encompassing of very short-term assignments, maybe 6 to 8 weeks plus the more traditional assignments of 13 weeks and our international assignments can -- which can span 18 to 24 months, because they're all contracted, multi-week or multi-month assignment. And they're serving, in some cases, a similar need in terms of short-term contingent staff, but also, they're often filling in for permanent staff. In the case of international, I'd say, they're -- the vast majority of them are converting to permanent staff. So I would look at those more in totality as opposed to just each individual segment. And if you do that, you can get to some really nice growth rates. In fact, international and rapid response were growing double digits last year. Collectively, if you combine that with the travel business, the traditional 13-week travel business, it brings it down into the single digits. But hopefully, that gives you a little bit of a glimpse.
嗯,我會先從更—我先從護理開始談,當然,如果我漏了什麼,也請 Ralph 在這裡補充。但我會把旅遊護理視為涵蓋所有類型:非常短期的派遣,可能 6 到 8 週,加上更傳統的 13 週派遣,以及我們的國際派遣—其期間可能長達 18 到 24 個月—因為它們都是以合約形式進行的、跨數週或數月的任務。在某些情況下,它們在短期彈性人力方面服務的是相似需求,但同時也常常是在補永久編制人員的缺口。以國際派遣來說,我會說—其中絕大多數最後都會轉為永久員工。所以我會更傾向把它們作為整體來看,而不是只看每個單一分項。如果你這樣看,就能得到一些相當不錯的成長率。事實上,國際與快速應變(rapid response)去年是雙位數成長。若把這些與旅遊業務、也就是傳統 13 週旅遊業務合併來看,整體就會被拉回到個位數成長。但希望這能讓你稍微看到一些輪廓。
Now the 13-week traditional travel business has plenty of demand to be growing double digits. Demand is not the challenge there. As we've been discussing in the last several quarters, supply has really been the constraint. So if we continue to see bill rates rise as we have, if we continue to see some incremental supply come into the market, we ought to be able to get that traditional 13-week business up into the mid, even high single digits, and quite honestly, it could go higher than that if the supply would begin to roll.
至於 13 週的傳統旅遊業務,其需求其實足以支撐雙位數成長。需求不是那裡的挑戰。如同我們過去幾個季度一直在討論的,供給才是真正的限制因素。所以如果我們持續看到帳單費率(bill rates)像目前這樣上升,如果我們也持續看到市場有一些增量供給進來,我們應該能把傳統 13 週業務拉升到中個位數、甚至高個位數;坦白說,如果供給開始真正回流,成長還可能更高。
Allied is a little bit more of a mixed bag because of the various disciplines. The therapy business is very strong. Although in skilled nursing, we've had that headwind because of reimbursement changes. But imaging, respiratory and lab has been where the biggest growth has been. In fact, it's really quite amazing to look at how that particular business has grown over the last decade. So Ralph, anything else you want to add?
Allied(醫事專業)這塊因為涵蓋多種專業領域,所以情況比較混合。治療(therapy)業務非常強。不過在專業護理機構(skilled nursing)方面,因為給付(reimbursement)變動,我們遇到一些逆風。但影像、呼吸治療與檢驗(lab)是成長最大的領域。事實上,回頭看這個業務在過去十年的成長,真的相當驚人。所以 Ralph,你還有什麼要補充的嗎?
Ralph S. Henderson - President of Professional Services & Staffing
Ralph S. Henderson - President of Professional Services & Staffing
You covered most of it. The diversity of the Allied business has actually been a positive because the skilled nursing being down and then the, as Susan mentioned, the imaging, respiratory and lab specialties and the schools also growing at a fast rate. I think our schools business is up about 50% year-over-year.
你大致都涵蓋到了。Allied 業務的多元性其實是正面因素,因為專業護理機構那邊下滑,但如 Susan 提到的,影像、呼吸治療與檢驗等專科,以及學校(schools)業務也都在快速成長。我想我們的學校業務年增大約 50%。
Operator
Operator
Next question comes from the line of Jason Plagman from Jefferies.
下一題來自 Jefferies 的 Jason Plagman。
Jason Michael Plagman - VP
Jason Michael Plagman - VP
So going back to travel nursing, I believe it was the last quarter, you mentioned that the premium -- you were seeing some pickup in the premium rate business, and you've obviously called out the rapid response. But any comments on what percentage of that -- of your total mix the premium assignments represented in Q4? And kind of what that trajectory is heading -- looking like heading into 2020?
回到旅遊護理,我記得應該是上個季度,你們提到高溢價(premium)—你們看到高溢價費率業務有些回升,而且你們也特別提到快速應變(rapid response)。那能否評論一下,在第四季(Q4)你們整體組合中,高溢價派遣大概占了多少比例?以及展望 2020 年,這個趨勢大概會往哪個方向走?
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Jason, this is Brian. You said, as we mentioned it, it has picked up again. I think what's -- we're shifting away from just talking about that exact percentage as if that's the only determinant of how our clients utilize our services. We're finding more often they're pulling on different clinicians when they need them. If it's -- they may have a traditional order in, if it becomes a more urgent need, they may flip to more of a rapid response, but really having that spectrum of opportunities. As Susan mentioned, all the way from kind of 6 to 8 weeks, all the way to 2-year assignment for the international business, really allows us to meet the need of the client at that time. So that percentage has gone up. We're not going to kind of give the exact number every quarter. We're not back to the levels we were a couple of years ago, but we're definitely off of the bottom we saw in 2018. It's been steadily rising through the back half of last year, not surprising, with demand going up so quickly and not seeing that underlying pricing growth, that more of our clients have had to kind of go back and forth between traditional and more of the rapid response or critical staffing rates. So it likely will go up a little bit more in the first quarter. But hopefully, that's also a good foundation for conversations with clients about the opportunity to increase those standard rates to bring more permanent supply back into the industry to fill more jobs as well.
Jason,我是 Brian。如你所說、也如我們提到的,它確實又回升了。我想我們正在—把焦點從只談那個精確比例,彷彿那是決定客戶如何使用我們服務的唯一因素,轉移開來。我們更常發現,客戶在需要時會調度不同類型的臨床人員。如果—他們可能原本下的是傳統訂單,但若需求變得更緊急,他們可能會切換到更偏快速應變;但重點是我們提供一整個機會光譜。如 Susan 提到的,從大約 6 到 8 週,一直到國際業務的 2 年派遣,確實讓我們能在當下滿足客戶的需求。所以那個比例是上升了。我們不會每一季都提供精確數字。我們還沒回到幾年前的水準,但我們肯定已經脫離 2018 年看到的低點。在去年下半年它穩步上升;這也不令人意外,因為需求上升得很快,但沒有看到底層定價的成長,因此更多客戶不得不在傳統方案與較偏快速應變或關鍵人力(critical staffing)費率之間來回切換。所以第一季它很可能還會再上升一些。但希望這也能為我們與客戶的對話奠定良好基礎,討論提高標準費率的機會,讓更多永久供給回到產業中,以填補更多職缺。
Jason Michael Plagman - VP
Jason Michael Plagman - VP
Great. That's helpful. And then any comment on the demand from your largest client? Is that -- should we expect that to continue to be a headwind in Q1? Or has that flattened out? Or how is that progressing from what you're seeing from the order flows and assignments in Q1?
很好。這很有幫助。另外,對於你們最大客戶的需求有什麼評論嗎?也就是說——我們是否應該預期這在第一季仍會是逆風?還是已經趨於平緩了?或者就你們在第一季看到的訂單流與派案情況而言,進展如何?
Ralph S. Henderson - President of Professional Services & Staffing
Ralph S. Henderson - President of Professional Services & Staffing
Yes. Good news on that one. While it did impact Q4 about the same as it had in the prior quarters last year. In Q1, we expect that it will be on par with prior year.
是的。這方面有好消息。雖然它對第四季的影響大致與去年前幾季相同。在第一季,我們預期會與去年同期持平。
Jason Michael Plagman - VP
Jason Michael Plagman - VP
Okay. Great. And then switching gears a little bit. I wanted to ask on the OWS segment, you're expecting 2% to 3% organic growth in Q1. Any items that could accelerate that closer to mid-single digits, 4% to 5%, as you progress through 2020? I know you'll start to lap some maybe easier comps in the rev cycle, but how should we be framing the trajectory in 2020 for the OWS segment?
好的。很好。接著稍微換個話題。我想問一下 OWS 部門,你們預期第一季有 2% 到 3% 的有機成長。在 2020 年進行的過程中,有沒有什麼因素可以讓它加速到接近中個位數,也就是 4% 到 5%?我知道你們在營收週期上可能會開始遇到一些較容易的比較基期,但我們應該如何看待 2020 年 OWS 部門的走勢?
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Jason, this is Brian. I'll just kick it off, and then let Kelly give some color as well. I think for the next couple of quarters, it's more likely to look pretty similar to the guidance we gave for Q1. We are stable now with the revenue cycle business, but stable at a lower level. The team's done a really nice job of kind of replacing some of the turnover that they saw and really starting to build the foundation. But it'll still be a negative comp for the next 2 to 3 quarters, I think. So that part is kind of a baseline starting point. As we go into Q2 and Q3, I think the opportunities are probably more in leadership solutions. I'll let Kelly give some color on that.
Jason,我是 Brian。我先開頭講一下,然後也讓 Kelly 補充一些細節。我認為接下來幾個季度,看起來更可能會與我們給第一季的指引相當接近。我們的營收週期業務現在已經穩定了,但穩定在較低的水準。團隊在補上他們所看到的一些人員流動、並真正開始打好基礎方面做得非常好。但我認為接下來 2 到 3 個季度仍會是負向比較基期。所以那部分算是一個基準起點。進入第二季與第三季時,我認為機會可能更多在領導力解決方案。我讓 Kelly 來補充一些說明。
Kelly E. Rakowski - President of Leadership & Search Solutions
Kelly E. Rakowski - President of Leadership & Search Solutions
Yes. And Jason, I'd say we are seeing good, steady volume. There's a couple of places where we could see some acceleration, RPO as we continue to strengthen our RPO capabilities and more closely tie our RPO solutions to our MSP clients as they move to more of that total talent solution. Those are the kinds of relationships that can bring in revenue faster. Also, our predictive analytics, where we've had several new signings each of the last couple of quarters in both consulting as well as our Smart Square scheduling technology solutions and a very strong pipeline there, and so we can scale up very quickly, particularly on the technology side. So there are some areas where we could see some acceleration.
是的。Jason,我會說我們看到良好且穩定的量能。有幾個地方可能會看到加速:RPO(招募流程外包),隨著我們持續強化 RPO 能力,並在 MSP 客戶轉向更完整的人才整體解決方案時,將我們的 RPO 解決方案與 MSP 客戶更緊密地連結。這類關係能更快帶來營收。另外是我們的預測分析,我們在過去幾個季度每一季都有數個新簽約,涵蓋顧問服務以及我們的 Smart Square 排班技術解決方案,而且那裡的案源管線非常強,因此我們可以很快擴張,特別是在技術端。所以確實有一些領域可能會看到加速。
Jason Michael Plagman - VP
Jason Michael Plagman - VP
Got it. And last one for me. Just an update on MSP contract activity in Q4. And what's the pipeline -- how that's looking for 2020, if we should be thinking that you can match kind of your last 2 years, they've both been record years, how is that looking for 2020?
了解。我最後一個問題。請更新一下第四季 MSP 合約活動的情況。以及 2020 年的案源管線——目前看起來如何?我們是否應該認為你們能夠匹配過去兩年的水準(兩年都是創紀錄的一年)?2020 年看起來如何?
Dan White - President of Strategic Workforce Solutions
Dan White - President of Strategic Workforce Solutions
Thanks, Jason. This is Dan. I'll take that one. So as you mentioned, 2019 ended up being our best MSP sales year ever, with about a 20% year-over-year improvement. We also had, just as color, about an 11% year-over-year improvement in the gross spend over management, which reflects contracts, not only signed, but when they go live and how they grow. That's now a little bit over $2.6 billion in total. Another nice trend that we're seeing is that we're getting contracts that are renewing at 5 or more years, more than really ever before also. One of the things you'd asked me about is how is Q1 going. We've started off very well. We have a number of client contracts that have already been signed. We have $70 million in contracting today. All of that stuff gives me great confidence that 2020 will continue to be a strong year for us. I think maybe even more important than just the base contracts, though, is our ability to cross-sell. Our -- if you look at our top 40 accounts, the number of added service lines in 2019 grew by a little over 35%, which gives me great confidence that we can take things like Stratus or b4health or some of these other additions to the portfolio and bring them into our clients more quickly.
謝謝,Jason。我是 Dan。我來回答這題。如你所提到的,2019 年最終成為我們史上最佳的 MSP 銷售年度,年增約 20%。另外補充一下,我們在受管理的總支出(gross spend over management)也年增約 11%,這反映的不只是簽約的合約,還包括合約上線以及後續成長的情況。目前總額已略高於 26 億美元。我們看到的另一個不錯趨勢是,續約年限達 5 年或以上的合約比以往任何時候都更多。你也問到第一季進展如何。我們開局非常好。我們已經簽下多份客戶合約。目前已有 7,000 萬美元的簽約金額。這些都讓我對 2020 年仍會是強勁的一年充滿信心。不過,我認為可能比基礎合約更重要的是我們的交叉銷售能力。如果你看我們前 40 大客戶,2019 年新增的服務線數量成長了超過 35%,這讓我很有信心,我們可以把像 Stratus、b4health 或投資組合中其他新增項目更快導入客戶。
Operator
Operator
(Operator Instructions) And we do have a question from the line of Mark Marcon from Baird.
(接線員指示) 我們接到來自 Baird 的 Mark Marcon 的提問。
Mark Steven Marcon - Senior Research Analyst
Mark Steven Marcon - Senior Research Analyst
I was wondering, with labor disruption, how much was the total revenue? I know it was $10 million more than you were expecting. What was the total and both for the quarter and the year?
我想請問,在勞動中斷(罷工)方面,總營收是多少?我知道比你們原先預期多了 1,000 萬美元。那麼季度與全年各自的總額是多少?
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Yes. It was closer to $15 million for the quarter, which is -- some of that we already had built into our guidance. We had some visibility in...
是的。就季度而言更接近 1,500 萬美元——其中一部分我們其實已經納入指引。我們有一些能見度在……
Mark Steven Marcon - Senior Research Analyst
Mark Steven Marcon - Senior Research Analyst
Sure.
好的。
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
(inaudible) third quarter call. For the full year, it was a little over $30 million. Pretty similar amount in both 2019 and 2018 at kind of low 30s. So 2 record years, by the way. So I don't want to assume that's going to happen. Actually, as we're sitting here kind of halfway through the first quarter, we really don't have any revenue at this point. And it's not certain whether we'll have any at all for the remainder of the quarter, which just speaks to the reason why we don't always call that out too much, because it's -- or we call it out specifically because it's -- it can be pretty variable quarter-to-quarter. There will be more activity through this year, but Q1 has been pretty quiet so far.
(聽不清楚) 第三季電話會議。就全年而言,略高於 3,000 萬美元。2019 年與 2018 年都差不多,約在 3,000 萬出頭。順帶一提,這兩年都是創紀錄的年份。所以我不想假設這一定會再發生。實際上,現在我們大概處於第一季過了一半的時間點,截至目前真的沒有任何營收。而且也不確定本季剩餘時間是否會有任何營收,這也說明了為什麼我們不會總是特別強調這一項——或者我們會特別點出來,因為它——每季之間的波動可能相當大。今年之後還會有更多活動,但到目前為止第一季相當平靜。
Mark Steven Marcon - Senior Research Analyst
Mark Steven Marcon - Senior Research Analyst
Okay. And how would you think about -- or how should we think about like the number of providers on assignments sequentially, just in terms of typical sequential flow, and what we ended up seeing in the fourth quarter?
好的。那你會怎麼看——或者我們應該怎麼看——派案中的供應者人數(providers)在季對季的變化?就典型的季節性變化而言,以及我們在第四季實際看到的情況?
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
For a normal season -- like from Q3 to Q4, you mean?
你是指一般季節性——例如從第三季到第四季嗎?
Mark Steven Marcon - Senior Research Analyst
Mark Steven Marcon - Senior Research Analyst
Yes.
是的。
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Yes. I say -- we gave the guidance, we talked about the fourth quarter for travel nursing particularly being a little bit softer than we normally see. Some of that being tied to the timing of the winter starts. So it came in generally in line with our expectation, but below what we'd normally see from Q3 to Q4. Now as we are looking into the first quarter, I mean considering the amount of strike revenue we ended up having in Q4, to see our guidance, excluding Stratus, looking pretty flat. That's actually a really nice performance and reflective of the growth we've seen sequentially in the underlying volume of the business, both -- and that's really true in nursing as well as even in Locums where the typical seasonality would be kind of maybe down a little bit from Q4 to Q1. We're actually expecting to be up a little bit based on that guidance. So seeing good trends as we're going into the first quarter.
是的。我會說——我們在指引中有提到,第四季就旅遊護理(travel nursing)而言,確實比我們通常看到的要稍微疲弱一些。其中一部分與冬季開工(winter starts)的時點有關。因此整體結果大致符合我們的預期,但低於我們通常從第三季到第四季會看到的水準。現在看第一季,我是說,考量到我們在第四季最終有的罷工營收規模,如果看我們的指引、排除 Stratus 之後看起來相當持平,這其實是非常好的表現,也反映了我們在業務底層量能的季對季成長——不論是在護理,甚至在代班醫師(Locums)方面也是如此;而按典型季節性,從第四季到第一季可能會小幅下滑。
Mark Steven Marcon - Senior Research Analyst
Mark Steven Marcon - Senior Research Analyst
Okay. Great. And then when we take a look at the EBITDA guidance in terms of 12.3% to 12.5%, but you've got half a quarter benefit from Stratus, which is higher. How should we think about that in terms of the -- what the puts and takes are from a year-over-year perspective, adjusting for Stratus?
好的。很好。接著我們看 EBITDA 指引為 12.3% 到 12.5%,但你們有來自 Stratus 的半個季度效益,而 Stratus 的利潤率更高。從年對年角度、並在調整 Stratus 影響後,我們應該如何看待其中的利多與利空(puts and takes)?
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Yes. The -- what I'd say is just that Stratus, as Susan mentioned, adds about, on a full quarter basis, closer to 80 basis points. So with that, half -- kind of essentially, with the expectation of closing tomorrow, we're picking up about 40 basis points of EBITDA margin in the first quarter. So that would push you back down to about 12%, which is similar to the guidance we gave for Q4. So the kind of underlying organic business performance is still operating in that 12% range. And then you add in Stratus into Q1. And so as you think about the second quarter, you would just add, again, obviously, a full quarter impact from Stratus.
是的。我會這麼說:如 Susan 提到,Stratus 若以完整一季計,約可增加接近 80 個基點。因此,若如預期明天完成交割,第一季我們大概會取得約 40 個基點的 EBITDA 利潤率提升。所以這會把你推回到約 12%,與我們對第四季給的指引相近。因此,基礎的有機業務表現仍在約 12% 的區間運行。然後在第一季把 Stratus 加進來。至於第二季,你就會再加上 Stratus 的影響,當然是完整一季的貢獻。
Mark Steven Marcon - Senior Research Analyst
Mark Steven Marcon - Senior Research Analyst
Great. And then...
很好。然後……
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
As we move through the year, obviously, we'd expect to see improvement in the margin, we would -- as we see the growth continue, we would start to pick up more operating leverage as we move into the third and fourth quarter. But I think that should give you a decent line of sight for Q1 and Q2.
隨著我們走過今年,顯然我們預期利潤率會改善;隨著成長持續,我們在第三與第四季會開始取得更多營運槓桿。但我認為這應該能讓你對第一季與第二季有相當清楚的能見度。
Mark Steven Marcon - Senior Research Analyst
Mark Steven Marcon - Senior Research Analyst
So orders are really high. Demand is really high. What's stopping some of the health care systems from raising the bill rates to a level where you can actually get more supply? I mean I'm sure that they've heard from you and others how tight it is. When would that break through?
所以訂單真的很高。需求真的很高。那是什麼阻止某些醫療體系把計費費率(bill rates)提高到能實際吸引更多供給的水準?我的意思是,我確定他們已經從你們和其他人那裡聽到市場有多緊。什麼時候才會突破?
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
Well, we are seeing progress. As we've said, we saw some nice underlying increases in the fourth quarter in that 3% range. It's improved even more than that going into the first quarter. And I'd say as you exit the first quarter, it's accelerating. But I think you find them being appropriately cautious about how much they need to increase those rates to get the supply. Now when they use more and more rapid response clinicians, that's usually a sign that the underlying regular bill rate needs to increase so that perhaps they can fill those jobs with more traditional lower-cost travelers rather than having that urgent need at the higher bill rate with rapid response. So I'd say we are actually making nice progress. They're just being very thoughtful about how that progresses.
嗯,我們確實看到進展。如我們所說,第四季我們看到約 3% 左右的不錯的基礎性上調。進入第一季後,改善幅度甚至更大。而且我會說,當你走出第一季時,這個趨勢正在加速。但我認為你會看到他們在需要把費率提高多少才能取得供給這件事上,保持適度謹慎。當他們使用越來越多的快速應變臨床人員(rapid response clinicians)時,通常就是一個訊號:基礎的常規計費費率需要上調,這樣他們或許就能用更傳統、成本較低的旅派人員(travelers)來補足職缺,而不是在急迫需求下以快速應變的較高計費費率來填補。所以我會說我們其實取得了不錯的進展。只是他們對於這個進程如何推進非常審慎。
Mark Steven Marcon - Senior Research Analyst
Mark Steven Marcon - Senior Research Analyst
Okay. I mean how much of a step -- would it take like more of a 5%, 6% change, 7%? I mean, when -- I'm sure you've looked at elasticity, you've got all sorts of data.
好的。我的意思是,需要多大幅度的調整——例如 5%、6%、7% 這樣?我是說,你們肯定看過彈性,也有各式各樣的數據。
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
We have. We have, Mark. But as you would expect, there's always multiple inputs and variables that feed into that analysis. So I would be hesitant to call a particular number and say things are going to break loose if we hit that number. But certainly, if we start to get above 5%, that would be a very good sign. I'd say even at the levels we're seeing now, we are more optimistic about supply improving and rebook rates, which remain very strong. And so I think we're getting close.
我們有。我們有的,Mark。但如你所預期,這類分析總是有多個輸入與變數會影響結果。所以我會很猶豫去點出某個特定數字,並說只要達到那個數字情況就會全面鬆動。但可以肯定的是,如果我們開始高於 5%,那會是一個非常好的訊號。我會說,即使在我們目前看到的水準下,我們對供給改善以及續約率(rebook rates,仍然非常強勁)也更為樂觀。所以我認為我們已經接近了。
Mark Steven Marcon - Senior Research Analyst
Mark Steven Marcon - Senior Research Analyst
Great. And then I remember having a conversation many years ago with you and Ralph with regards to float pools. And b4 (sic) [b4health] is a really interesting -- I will -- it seems intuitive to me. How many of your clients are currently using them? And what's their position relative to that kind of solution? Because that's a truly -- that's clearly a trend.
很好。然後我記得很多年前曾和你以及 Ralph 談過 float pools(浮動人力池)。而 b4(原文如此)[b4health] 是個非常有趣的——我會說——對我來說很直覺。你們目前有多少客戶正在使用它們?他們對這類解決方案的立場如何?因為這確實——這顯然是一個趨勢。
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
Yes. I agree. I love this business and the technology. And again, the team there is just so innovative. So thank you for recognizing that. We actually don't have as much overlap as you would think, because they are a newer business, and they have some really fantastic, prestigious, impressive clients that also happen to be our clients in other ways. But the fact that we can have some referenceable accounts that they bring to the table, I think, gives us that much more capability, but also credibility to be able to go to our other large strategic clients and show what is possible. So we think there is a lot of opportunity here with our existing clients. And quite honestly, there's not been much innovation in this space beyond what b4health has done. There are certainly legacy scheduling technology companies that have some capabilities, but not to the extent that b4health has created in terms of it being cloud-based, mobile-enabled, integrated with other systems. That's really where the sort of the secret sauce comes in, is that it doesn't just stand alone in a silo. It's very well integrated with the hospital systems, but also with their other staffing providers.
是的。我同意。我很喜歡這個業務和這項技術。而且那邊的團隊真的非常創新。所以謝謝你注意到這點。其實我們的客戶重疊度沒有你想的那麼高,因為他們是較新的業務;他們有一些非常出色、具聲望、令人印象深刻的客戶,而這些客戶也剛好在其他方面是我們的客戶。但他們能帶來一些可作為參考案例的客戶帳戶,我認為這不僅讓我們能力更強,也讓我們在面向其他大型策略性客戶時更具可信度,去展示什麼是可能做到的。因此,我們認為在既有客戶中有很大的機會。坦白說,除了 b4health 所做的之外,這個領域並沒有太多創新。當然也有一些傳統的排班技術公司具備部分能力,但在雲端化、行動化、以及與其他系統整合等方面,遠不及 b4health 所打造的程度。真正的「獨門配方」就在這裡:它不只是孤立地在一個筒倉裡單獨運作。它與醫院系統整合得非常好,也能與他們的其他人力供應商很好地整合。
Mark Steven Marcon - Senior Research Analyst
Mark Steven Marcon - Senior Research Analyst
That's great. And then revenue cycle, it sounds like things have stabilized, and we're in a decent shape going forward, or...?
這很棒。然後關於營收循環(revenue cycle),聽起來情況已經穩定下來了,我們未來的狀態不錯,還是……?
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
Yes. I think that's a great way to put it. It's in a stable position. There are certainly bright spots within the business, but then there are others, such as the CDI and coding parts of the business, where we've felt a little bit more of a contraction. Again, we think it's more a factor of disruption and the changes that we've made over the last year, which we feel were very much needed in order to set the stage for the business to grow in a healthy way moving forward. We also brought together 2 brands, Peak and MedPartners. And when you do that, there's always a bit of disruption. So we feel that we are through that and poised to begin to grow as we go into sort of the middle part of the year is probably a reasonable time frame.
是的。我覺得這樣形容很貼切。它處於穩定的狀態。業務中確實有一些亮點,但也有一些部分,例如 CDI 與編碼(coding)業務,我們感受到些許收縮。同樣地,我們認為這更多是因為過去一年我們所做的調整所帶來的擾動與變化;我們覺得那些調整非常必要,才能為業務未來以健康方式成長奠定基礎。我們也把兩個品牌 Peak 和 MedPartners 整合在一起。而當你做這件事時,總會有一些擾動。所以我們覺得已經度過那段期間,並且蓄勢待發;大概在年中的那段時間開始恢復成長,是一個合理的時間框架。
Mark Steven Marcon - Senior Research Analyst
Mark Steven Marcon - Senior Research Analyst
Great. And then can you just talk about the pace of delevering? And the cash flow from operations that you're envisioning over the next year to 2? And my assumption is you definitely wouldn't do an equity raise to pay down any of the debt, but just wanted to -- just absolutely confirm that.
很好。那你能談談去槓桿(delevering)的節奏嗎?以及你們對未來 1 到 2 年營運現金流(cash flow from operations)的預期?我的假設是你們肯定不會為了償還任何債務而進行增資(equity raise),但我只是想——想要完全確認一下。
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Sure. No. This is Brian. We don't intend to at this point. We've got a very solid debt structure with a blend of both long-term unsecured debt and now mixed in with the credit facility that we'll be drawing on tomorrow for the acquisition. Again, as I mentioned, it's a 5-year term loan, resetting the revolver also for a new 5-year basis, and we've got plenty of room within our covenants. So with the pro forma leverage expected to be 3.3x at closing, we'll be able to -- all of that debt will be prepayable. So we're able to take our cash flow and immediately start paying it down. If you look at our full year operating cash flow in 2019 of $229 million, so on a free cash flow basis, you're up just a little under $200 million. So it gives you a sense of the kind of cash flow we'll be expected to generate this year on a quarterly basis, between kind of $40 million and $60 million. And so we'll be able to use that to delever as well. So as I mentioned, even when we had the call when we announced the transaction, we would expect to be below 3x leverage by the end of this year. So we feel really good about our position on the balance sheet.
當然。不。我是 Brian。我們目前沒有這個打算。我們的債務結構非常穩健,結合了長期無擔保債務,並且現在也搭配了我們將於明天為本次收購動用的信貸額度。再重申一次,如我提到的,這是一筆 5 年期定期貸款,同時也把循環信貸(revolver)重設為新的 5 年期架構,而且我們在各項財務契約(covenants)限制內仍有充足空間。因此,以交割時預期的備考槓桿倍數(pro forma leverage)3.3 倍來看,我們將能夠——而且所有這些債務都可提前償還。所以我們可以運用現金流,立即開始償還債務。如果你看我們 2019 年全年營運現金流為 2.29 億美元,以自由現金流(free cash flow)口徑來看,略低於 2 億美元。因此,這能讓你大致了解我們今年按季度預期可產生的現金流規模,大約在 4,000 萬到 6,000 萬美元之間。因此我們也能用這些現金流來去槓桿(deleverage)。所以如我提到的,即使在我們宣布交易時的電話會議上,我們也預期在今年年底前把槓桿降到 3 倍以下。所以我們對資產負債表上的狀況感到非常有信心。
Operator
Operator
Next, we have a question from the line of Tim Mulrooney from William Blair.
接下來,我們有一個問題來自 William Blair 的 Tim Mulrooney。
Timothy Michael Mulrooney - Analyst
Timothy Michael Mulrooney - Analyst
I want to ask Mark's question a different way on Stratus. What's baked into the first quarter guide from Stratus on the bottom line? If you did -- if you just kind of take the numbers you gave us from last year, I'd assume $9 million, maybe about $9 million for a full quarter. So given it's about half a quarter, does about $5 million seem right?
我想用不同方式來問 Mark 關於 Stratus 的問題。Stratus 第一季指引在損益底線(bottom line)方面,已經反映了哪些假設?如果你把去年給我們的數字簡單套用,我會假設一整季大概是 900 萬美元,可能約 900 萬美元。所以既然大概只有半季,那約 500 萬美元看起來合理嗎?
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Pretty close. It's probably more in the $4.5 million range. So as we mentioned it, it's running at about a 28% EBITDA margin. So if you take the $15 million at the 28%, it should give you a pretty good sense of expectation for the quarter.
很接近。可能更接近 450 萬美元左右。如我們提到的,它的 EBITDA 利潤率大約是 28%。所以如果你用 1,500 萬美元乘以 28%,應該就能對本季的預期有相當好的概念。
Timothy Michael Mulrooney - Analyst
Timothy Michael Mulrooney - Analyst
Perfect. And in the Other Workforce Solutions, gross margin was up 260 basis points, I think, you said, due to favorable mix shift. Maybe it's just because I'm new to the story, but I'm not sure what exactly was driving that? So what are those mix shifts specifically? And how do you see that carrying through the next several quarters?
很好。另外,在 Other Workforce Solutions(其他人力解決方案)方面,你說毛利率上升了 260 個基點,應該是因為有利的組合變化(mix shift)。也許只是因為我剛接觸這個故事,但我不太確定到底是什麼在驅動這件事?所以這些組合變化具體是哪些?你怎麼看它在接下來幾個季度的延續性?
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Sure. Within OWS, yes. So part of it is the revenue cycle business being down.
當然。是在 OWS 之內,沒錯。其中一部分原因是收入週期(revenue cycle)業務下滑。
Timothy Michael Mulrooney - Analyst
Timothy Michael Mulrooney - Analyst
Yes.
是的。
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
It has a lower gross margin than the other business lines. So just purely by that business being down relative to some other ones, that has a favorable impact on the gross and EBITDA margin. And then on top of that, we saw a nice growth in our leadership search business, we've got particularly strength in the physician perm business, which has a -- is a higher margin, slightly higher margin than average, as well as in our -- the technology businesses, VMS, Avantas were both up nicely year-over-year, and those carry a higher-than-average margin for the segment as well.
它的毛利率比其他業務線更低。所以單純因為這項業務相對於其他業務下滑,就會對毛利率與 EBITDA 利潤率帶來有利影響。此外,我們的高階人才搜尋(leadership search)業務也有不錯的成長,尤其是醫師永久職(physician perm)業務表現強勁,該業務的利潤率——比平均略高;同時在我們的——科技業務方面,VMS、Avantas 兩者年增都相當不錯,而它們在該分部也同樣具有高於平均的利潤率。
In terms of expectation, I mean it would be pretty similar then as you roll into the first quarter, because we have a pretty similar expectation now. It will be influenced now going forward with Stratus as we -- as you think about the higher margin profile of that business as well.
就預期而言,我的意思是,當你進入第一季時情況會相當類似,因為我們現在的預期也很相近。而往後也會受到 Stratus 的影響,因為——當你考量該業務較高的利潤率特性時也是如此。
Timothy Michael Mulrooney - Analyst
Timothy Michael Mulrooney - Analyst
So is there a point at which this dynamic, excluding Stratus, this dynamic laps itself? Did this start to happen several quarters ago? Or would you expect basically that to carry through 2019 -- or 2020, excuse me?
所以是否存在某個時間點,這個動態(不含 Stratus)會自行消失(lapse)?這是從幾個季度前就開始發生的嗎?或者你基本上預期它會延續到 2019——呃,抱歉,是 2020 年?
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
So again, we would expect to see the revenue cycle business start to improve as we move through the year, but we would also will see growth across the other businesses. So it's unlikely the margin profile will change significantly. And I mentioned Stratus, actually, the gross margin on that business is closer to 45%. So actually a little bit lower, but EBITDA margins are higher as well. So those will -- that will have an influence a little bit of a downdraft in the segment going forward. But I don't think you're going to see a big change from where we are, other than that Stratus being added in for a full quarter.
所以再說一次,我們預期收入週期業務會在今年推進的過程中開始改善,但我們也會看到其他業務全面成長。因此,利潤率結構不太可能出現顯著變化。另外我提到 Stratus,其實那項業務的毛利率更接近 45%。所以其實毛利率略低一些,但 EBITDA 利潤率也更高。因此,這些因素——會對該分部未來帶來一些向下的拖累(downdraft)。但我不認為你會看到相較於目前有很大的變化,除了 Stratus 以完整一季納入之外。
Timothy Michael Mulrooney - Analyst
Timothy Michael Mulrooney - Analyst
Okay. Okay. And one more for me. Brian, given the acquisitions of Advanced Medical, and now Stratus Video, can you give us an update on the capital allocation strategy for 2020? Should we expect a pause in M&A while you digest these acquisitions with cash applied towards deleveraging the balance sheet? Or how should we think about it overall?
好的。好的。我還有最後一個問題。Brian,考量到收購 Advanced Medical,以及現在的 Stratus Video,你能否更新一下 2020 年的資本配置策略(capital allocation strategy)?我們是否應該預期在你消化這些收購期間,暫停併購(M&A),並把現金用於降低資產負債表槓桿?或者整體上我們應該如何看待?
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
Sure. Sure. Maybe I'll start with that. So I think the short answer is, yes, there won't be a complete pause. We still certainly have capacity and should be looking at things that could be tuck-in opportunities or strategic additions to our Workforce Solutions, perhaps if they're technology solutions in particular. But we'll be very focused on, not just paying down debt, but also making sure that we are aligning our resources to the successful integration of Advanced, which has gone very, very well, but we still have some things to finish there. And then, of course, Stratus. I will say with Stratus, there's not as much integration as there might be if it were a staffing organization, because they have very different systems and platforms, so there's not as much to integrate on the front office. Certainly, there might be a few back office things. But even then, if they are heavily interwoven with their front and back office, we may not be integrating as much there. So it's probably [quantitatively] a lighter lift from an integration standpoint.
當然。當然。也許我先回答。我想簡短的答案是:是的,不會完全暫停。我們當然仍有能力,也應該持續尋找可能的補強型(tuck-in)機會或對我們 Workforce Solutions 具有策略性增補的標的,特別是如果它們是科技解決方案。但我們會非常專注於,不僅是償還債務,也要確保我們把資源對齊到 Advanced 的成功整合;那邊進展非常、非常順利,但仍有一些事項需要完成。然後當然還有 Stratus。我會說,Stratus 的整合需求不像人力派遣組織那麼多,因為他們有非常不同的系統與平台,所以前台(front office)需要整合的部分不多。當然,後台(back office)可能會有少數事項。但即便如此,如果他們的前後台高度交織,我們可能也不會在那裡做太多整合。所以從整合角度來看,這可能在[量化上]是比較輕量的工作。
Operator
Operator
And our next question comes from the line of Henry Chien from BMO.
接下來的問題來自 BMO 的 Henry Chien。
Sou Chien - Senior Associate
Sou Chien - Senior Associate
So there's a couple of moving parts, I just want to make sure I understand some of the trends. So I guess, first, from the organic standpoint, the growth in EBITDA, what was sort of the change there, just to understand, like the core profitability of the business, excluding acquisitions?
這裡有幾個變動因素,我只是想確認我理解了一些趨勢。所以我想,首先從有機(organic)的角度來看,EBITDA 的成長,那裡的變化大概是什麼?只是想了解一下,例如在排除收購的情況下,業務核心獲利能力(core profitability)如何?
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
In the fourth quarter?
在第四季嗎?
Sou Chien - Senior Associate
Sou Chien - Senior Associate
Yes. In the fourth quarter, yes.
是的。在第四季,是的。
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Yes. I don't know if we really break out the EBITDA. I mean the margin profile of -- I mean Advanced would have been the most kind of notable impact to the quarter, and they run at just a slightly higher EBITDA margin than the core business. So it would be a pretty similar underlying margin. We talked about a 12% EBITDA margin ex this, the impact we saw from the strike. So again, that was the bigger influence in the fourth quarter. But if you remove the impact of that -- of the strikes on the margin, it's really not notably different, whether kind of an organic or on a reported basis in Q4. Again, we talked about the impact with now this recent acquisition of Stratus, that'll have a more meaningful impact going forward. Q4 is not a big influence either way.
是的。我不確定我們是否真的會把 EBITDA 單獨拆分出來。我的意思是,利潤率輪廓——我是說 Advanced 對本季的影響會是最顯著的,而且他們的 EBITDA 利潤率只比核心業務略高一些。所以基礎利潤率會相當接近。我們談到過,若排除這個因素,我們的 EBITDA 利潤率是 12%,也就是排除我們看到的罷工影響。所以再次強調,這是第四季更大的影響因素。但如果你把罷工對利潤率的影響拿掉——無論是以有機口徑或以報告口徑來看第四季,其實並沒有顯著差異。同樣地,我們也談到,隨著近期收購 Stratus,未來將會帶來更有意義的影響。第四季不論哪一邊都不是很大的影響因素。
Sou Chien - Senior Associate
Sou Chien - Senior Associate
Okay. All right. That makes sense. And then just like the underlying volume trend, so I understand that travel volume is doing quite well and Allied is having some impact from reimbursement changes, just sort of the step down in organic growth from -- or not step down, I should say, but just some of the slowing from the mid single-digit range to the 2% to 3% range. Is there anything else going on just to be aware of? And I guess, we'll be keeping out for any other potential payment changes throughout this year.
好的。好。這說得通。接著就基礎的量的趨勢來看,我理解旅遊量表現相當不錯,而 Allied 受到報銷變更的一些影響;只是有機成長從——或者我不該說是下滑——而是從中個位數區間放緩到 2% 到 3% 的區間。還有沒有其他需要注意的事情?我想我們今年也會持續留意是否還有其他潛在的支付變更。
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
No. I don't think there's anything else that you're missing. There was PDGM introduced at the beginning of the year, we knew about it last year, but that was a reimbursement change that's affecting the home health industry. We don't, of course, bill directly and receive reimbursement, but our clients do. And so it can affect how they utilize, in this case, therapy resources, and so that hit in the first quarter. Again, we were anticipating it, so we began to redirect many of our resources to other disciplines or other settings and have been fairly successful with that. And in fact, there's been so far, a bit of an offset, where some of the home health providers have increased their utilization of nurses. And so I think we still want to kind of wait to see how much of an impact that will be. It's actually a fairly small part of our overall business, which is why we don't really call it out, but that would be another moving part in there that still probably needs to play out a little bit.
沒有。我不認為你漏掉了其他什麼。年初導入了 PDGM,我們去年就知道了,但那是一項影響居家健康(home health)產業的報銷變更。當然,我們不會直接開立帳單並收取報銷,但我們的客戶會。因此,這可能會影響他們如何使用——在這個案例中是——治療資源,所以第一季就受到衝擊。同樣地,我們原本就預期會發生,因此我們開始把許多資源重新導向其他專業領域或其他場域,而且在這方面相當成功。事實上,到目前為止也出現了一些抵銷效果,因為部分居家健康服務提供者提高了對護理人員的使用。所以我認為我們仍希望再觀察一下這會帶來多大的影響。這其實只占我們整體業務中相當小的一部分,這也是為什麼我們沒有特別點出來,但這會是其中另一個變動因素,可能還需要再發酵一段時間。
Operator
Operator
And there are no further questions in the phone queue at this time.
目前電話排隊中沒有其他問題。
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
Okay. Wonderful. Well, we really appreciate everybody joining us today. Thank you for your patience at the beginning of the call, as we worked through some technical difficulties, but really glad you could join us.
好的。太好了。我們非常感謝大家今天加入我們。也感謝各位在電話會議一開始的耐心等待,因為我們處理了一些技術問題,但很高興你們能參與。
And we wish you all a wonderful Valentine's Day tomorrow. I know we'll all be celebrating with our loved ones, but that also now includes the Stratus team that will be joining the AMN family. We're very excited about that. So everyone, have a great evening. Thank you.
也祝大家明天情人節愉快。我知道我們都會和所愛的人一起慶祝,但現在也包括即將加入 AMN 大家庭的 Stratus 團隊。我們對此非常興奮。各位,祝大家晚安。謝謝。
Operator
Operator
And ladies and gentlemen, this conference will be available for replay after 4:00 p.m. today through Thursday, February 27. You may access the AT&T executive replay system at any time by dialing 1 (866) 207-1041 and entering the access code 2857669. International participants may dial (402) 970-0847. Those numbers are, again, 1 (866) 207-1041 and (402) 970-0847, with an access code of 2857669. And that does conclude our conference for today. Thank you for your participation and for using AT&T conferencing services. You may now disconnect.
各位女士先生,本次電話會議將於今天下午 4:00 之後提供重播,至 2 月 27 日(星期四)止。您可隨時撥打 1 (866) 207-1041 並輸入存取碼 2857669,以使用 AT&T 高階主管重播系統。國際參與者可撥打 (402) 970-0847。上述號碼再次為 1 (866) 207-1041 與 (402) 970-0847,存取碼為 2857669。以上即為我們今天的電話會議內容。感謝您的參與並使用 AT&T 會議服務。您現在可以掛線。